Drug Type mRNA |
Synonyms XPACE 1006, XPACE1006 |
Target |
Action modulators |
Mechanism IL-10 modulators(Interleukin-10 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammatory Bowel Diseases | Preclinical | United States | 01 Mar 2025 |





